A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Bibliographic Details
Main Authors: Serrano, Davide, Lazzeroni, Matteo, Gandini, Sara, Macis, Debora, Johansson, Harriet, Gjerde, Jennifer, Lien, Ernst, Feroce, Irene, Pruneri, Giancarlo, Sandri, Maria Teresa, Bassi, Fabio, Brenelli, Fabricio, Luini, Alberto, Cazzaniga, Massimiliano, Varricchio, Clara, Guerrieri-Gonzaga, Aliana, DeCensi, Andrea, Bonanni, Bernardo
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053157/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053157/

Similar Items